Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression

BMC Bioinformatics

Volumn 12, Issue SUPPL. 13, 2011, Pages

  Lee, Sheng An ^a   Tsao, Theresa T ^b   Yang, Ko Chun ^b   Lin, Han ^b   Kuo, Yu Lun ^b   Hsu, Chien Hsiang ^b   Lee, Wen Kuei ^c   Huang, Kuo Chuan ^b,c   Kao, Cheng Yan ^b  

^a KAINAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Beitou Armed Forces Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIC STRESS; BIPOLAR DISORDER; BRAIN SAMPLE; CONTROL SAMPLES; CYTOSKELETONS; DISEASE GENES; DISEASE MARKERS; DRUG TARGETS; EXPRESSED GENES; FUNCTIONAL MODULES; HEAT-SHOCK; HOUSEKEEPING FUNCTIONS; MAJOR DEPRESSIONS; MARKER GENES; MENTAL DISEASE; NEURON CELLS; POTENTIAL TARGETS; PPI NETWORKS; PREFRONTAL CORTEX; PROTEIN-PROTEIN INTERACTION NETWORKS; PROTEIN-PROTEIN INTERACTIONS; PROTEOMICS; SINGLE NUCLEOTIDE POLYMORPHISMS; STRESS RESPONSE; SUB-NETWORK; T-TESTS; TOPOLOGICAL ANALYSIS;

DISEASES; ELECTRIC SWITCHBOARDS; ENERGY CONVERSION; GENES; HEATING; MOLECULAR BIOLOGY; PROTEINS; SIGNAL TRANSDUCTION; TOPOLOGY; TRANSCRIPTION; BIOINFORMATICS; DISEASE CONTROL;

DISEASE CONTROL; TRANSCRIPTION;

ARTICLE; BIPOLAR DISORDER; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MAJOR DEPRESSION; METABOLISM; PREFRONTAL CORTEX; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; GENE EXPRESSION PROFILING; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; PROTEIN INTERACTION MAPS; PROTEOMICS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 84864033725     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-12-S13-S20     Document Type: Article

References (102)

1. Harrison PJ. Using our brains: the findings, flaws, and future of postmortem studies of psychiatric disorders. Biol Psychiatry 2011, 69:102-103. 10.1016/j.biopsych.2010.09.008, 21183008.
2. Egan MF, el-Mallakh RS, Suddath RL, Lohr JB, Bracha HS, Wyatt RJ. Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophrenia. Psychiatry Res 1992, 43:187-195. 10.1016/0165-1781(92)90133-N, 1357702.
3. Heckers S, Heinsen H, Geiger B, Beckmann H. Hippocampal neuron number in schizophrenia. A stereological study. Arch Gen Psychiatry 1991, 48:1002-1008. 10.1001/archpsyc.1991.01810350042006, 1747014.
4. Goode DJ, Manning AA. Specific imbalance of right and left sided motor neuron excitability in schizophrenia. J Neurol Neurosurg Psychiatry 1988, 51:626-629. 10.1136/jnnp.51.5.626, 1033065, 3404162.
5. Young KA, Holcomb LA, Yazdani U, Hicks PB, German DC. Elevated neuron number in the limbic thalamus in major depression. Am J Psychiatry 2004, 161:1270-1277. 10.1176/appi.ajp.161.7.1270, 15229061.
6. Manaye KF, Lei DL, Tizabi Y, Davila-Garcia MI, Mouton PR, Kelly PH. Selective neuron loss in the paraventricular nucleus of hypothalamus in patients suffering from major depression and bipolar disorder. J Neuropathol Exp Neurol 2005, 64:224-229.
7. Schmidt K, Nolte-Zenker B, Patzer J, Bauer M, Schmidt LG, Heinz A. Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence. Pharmacopsychiatry 2001, 34:66-72. 10.1055/s-2001-15184, 11302566.
8. Benkert O, Grunder G, Wetzel H. Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression. Pharmacopsychiatry 1992, 25:254-260. 10.1055/s-2007-1014417, 1362997.
9. Zhan L, Kerr JR, Lafuente MJ, Maclean A, Chibalina MV, Liu B, Burke B, Bevan S, Nasir J. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder. Neuropathol Appl Neurobiol 2011, 37:206-219. 10.1111/j.1365-2990.2010.01128.x, 20874815.
10. Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 2002, 12:386-394. 10.1093/cercor/12.4.386, 11884354.
11. Cotter DR, Pariante CM, Everall IP. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 2001, 55:585-595. 10.1016/S0361-9230(01)00527-5, 11576755.
12. Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001, 58:545-553. 10.1001/archpsyc.58.6.545, 11386983.
13. Ongur D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM, Renshaw PF. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry 2008, 64:718-726. 10.1016/j.biopsych.2008.05.014, 2577764, 18602089.
14. Bowley MP, Drevets WC, Ongur D, Price JL. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 2002, 52:404-412. 10.1016/S0006-3223(02)01404-X, 12242056.
15. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 1998, 95:13290-13295. 10.1073/pnas.95.22.13290, 23786, 9789081.
16. Maier W, Hofgen B, Zobel A, Rietschel M. Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes?. Eur Arch Psychiatry Clin Neurosci 2005, 255:159-166. 10.1007/s00406-005-0583-9, 15995899.
17. Berrettini W. Bipolar disorder and schizophrenia: not so distant relatives?. World Psychiatry 2003, 2:68-72. 1525081, 16946898.
18. Harris LW, Lockstone HE, Khaitovich P, Weickert CS, Webster MJ, Bahn S. Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia. BMC Med Genomics 2009, 2:28. 10.1186/1755-8794-2-28, 2694209, 19457239.
19. Harris LW, Wayland M, Lan M, Ryan M, Giger T, Lockstone H, Wuethrich I, Mimmack M, Wang L, Kotter M, et al. The cerebral microvasculature in schizophrenia: a laser capture microdissection study. PLoS One 2008, 3:e3964. 10.1371/journal.pone.0003964, 2597747, 19088852.
20. Rollins B, Martin MV, Sequeira PA, Moon EA, Morgan LZ, Watson SJ, Schatzberg A, Akil H, Myers RM, Jones EG, et al. Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One 2009, 4:e4913. 10.1371/journal.pone.0004913, 2654519, 19290059.
21. Mehta D, Menke A, Binder EB. Gene expression studies in major depression. Curr Psychiatry Rep 2010, 12:135-144. 10.1007/s11920-010-0100-3, 2847693, 20425299.
22. Iwamoto K, Bundo M, Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 2005, 14:241-253.
23. Iwamoto K, Bundo M, Washizuka S, Kakiuchi C, Kato T. Expression of HSPF1 and LIM in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. J Hum Genet 2004, 49:227-231. 10.1007/s10038-004-0136-5, 15362566.
24. Choi KH, Zepp ME, Higgs BW, Weickert CS, Webster MJ. Expression profiles of schizophrenia susceptibility genes during human prefrontal cortical development. J Psychiatry Neurosci 2009, 34:450-458. 2783436, 19949721.
25. Kim S, Webster MJ. Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol Psychiatry 2010, 15:326-336. 10.1038/mp.2008.99, 18762803.
26. Klempan TA, Ernst C, Deleva V, Labonte B, Turecki G. Characterization of QKI gene expression, genetics, and epigenetics in suicide victims with major depressive disorder. Biol Psychiatry 2009, 66:824-831. 10.1016/j.biopsych.2009.05.010, 19545858.
27. Klempan TA, Sequeira A, Canetti L, Lalovic A, Ernst C, ffrench-Mullen J, Turecki G. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry 2009, 14:175-189. 10.1038/sj.mp.4002110, 17938633.
28. Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V, Rehal S, Klempan T, Gratton A, Benkelfat C, et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009, 4:e6585. 10.1371/journal.pone.0006585, 2719799, 19668376.
29. Choi KH, Elashoff M, Higgs BW, Song J, Kim S, Sabunciyan S, Diglisic S, Yolken RH, Knable MB, Torrey EF, Webster MJ. Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry 2008, 8:87. 10.1186/1471-244X-8-87, 2585075, 18992145.
30. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 2001, 98:4746-4751. 10.1073/pnas.081071198, 31905, 11296301.
31. Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, Barchas JD, Schatzberg AF, Myers RM, Akil H, Watson SJ. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry 2010,
32. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004, 9:684-697. 643.
33. Kim S, Choi KH, Baykiz AF, Gershenfeld HK. Suicide candidate genes associated with bipolar disorder and schizophrenia: an exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genomics 2007, 8:413. 10.1186/1471-2164-8-413, 2211497, 17997842.
34. Webster MJ, O'Grady J, Kleinman JE, Weickert CS. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 2005, 133:453-461. 10.1016/j.neuroscience.2005.02.037, 15885920.
35. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003, 23:6315-6326.
36. Hsu PC, Yang UC, Shih KH, Liu CM, Liu YL, Hwu HG. A protein interaction based model for schizophrenia study. BMC Bioinformatics 2008, 9(Suppl 12):S23. 10.1186/1471-2105-9-S12-S23, 2638163, 19091023.
37. Lee SA, Chan CH, Chen TC, Yang CY, Huang KC, Tsai CH, Lai JM, Wang FS, Kao CY, Huang CY. POINeT: protein interactome with sub-network analysis and hub prioritization. BMC Bioinformatics 2009, 10:114. 10.1186/1471-2105-10-114, 2683814, 19379523.
38. Hubbell E, Liu WM, Mei R. Robust estimators for expression analysis. Bioinformatics 2002, 18:1585-1592. 10.1093/bioinformatics/18.12.1585, 12490442.
39. Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 2004, 9:406-416. 10.1038/sj.mp.4001437, 14743183.
40. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 2004, 101:6062-6067. 10.1073/pnas.0400782101, 395923, 15075390.
41. Chen TC, Lee SA, Chan CH, Juang YL, Hong YR, Huang YH, Lai JM, Kao CY, Huang CY. Cliques in mitotic spindle network bring kinetochore-associated complexes to form dependence pathway. Proteomics 2009, 9:4048-4062. 10.1002/pmic.200900231, 19658104.
42. Spirin V, Mirny LA. Protein complexes and functional modules in molecular networks. P Natl Acad Sci USA 2003, 100:12123-12128.
43. Ruepp A, Waegele B, Lechner M, Brauner B, Dunger-Kaltenbach I, Fobo G, Frishman G, Montrone C, Mewes HW. CORUM: the comprehensive resource of mammalian protein complexes--2009. Nucleic Acids Res 2010, 38:D497-501. 10.1093/nar/gkp914, 2808912, 19884131.
44. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, et al. Human Protein Reference Database--2009 update. Nucleic Acids Res 2009, 37:D767-772. 10.1093/nar/gkn892, 2686490, 18988627.
45. Junker BH, Koschutzki D, Schreiber F. Exploration of biological network centralities with CentiBiN. BMC Bioinformatics 2006, 7:219. 10.1186/1471-2105-7-219, 1524990, 16630347.
46. Jeong H, Mason SP, Barabasi AL, Oltvai ZN. Lethality and centrality in protein networks. Nature 2001, 411:41-42. 10.1038/35075138, 11333967.
47. Hsu DF, Taksa I. Comparing rank and score combination methods for data fusion in information retrieval. Inform Retrieval 2005, 8:449-480.
48. Camon E, Magrane M, Barrell D, Lee V, Dimmer E, Maslen J, Binns D, Harte N, Lopez R, Apweiler R. The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology. Nucleic Acids Research 2004, 32:D262-D266. 10.1093/nar/gkh021, 308756, 14681408.
49. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3. 10.1186/gb-2003-4-5-p3, 12734009.
50. Medina I, Carbonell J, Pulido L, Madeira SC, Goetz S, Conesa A, Tarraga J, Pascual-Montano A, Nogales-Cadenas R, Santoyo J, et al. Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 2010, 38:W210-213. 10.1093/nar/gkq388, 2896184, 20478823.
51. Al-Shahrour F, Minguez P, Tarraga J, Medina I, Alloza E, Montaner D, Dopazo J. FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments. Nucleic Acids Res 2007, 35:W91-96. 10.1093/nar/gkm260, 1933151, 17478504.
52. Yu W, Clyne M, Khoury MJ, Gwinn M. Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associations. Bioinformatics 2010, 26:145-146. 10.1093/bioinformatics/btp618, 2796820, 19864262.
53. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009, 106:9362-9367. 10.1073/pnas.0903103106, 2687147, 19474294.
54. Stenson PD, Ball EV, Howells K, Phillips AD, Mort M, Cooper DN. The Human Gene Mutation Database: providing a comprehensive central mutation database for molecular diagnostics and personalized genomics. Hum Genomics 2009, 4:69-72.
55. Andreasen NC, Nopoulos P, O'Leary DS, Miller DD, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry 1999, 46:908-920. 10.1016/S0006-3223(99)00152-3, 10509174.
56. Koechlin E, Hyafil A. Anterior prefrontal function and the limits of human decision-making. Science 2007, 318:594-598. 10.1126/science.1142995, 17962551.
57. Glatt SJ, Chandler SD, Bousman CA, Chana G, Lucero GR, Tatro E, May T, Lohr JB, Kremen WS, Everall IP, Tsuang MT. Alternatively spliced genes as biomarkers for schizophrenia, bipolar disorder and psychosis: a blood-based spliceome-profiling exploratory study. Curr Pharmacogenomics Person Med 2009, 7:164-188. 3083864, 21532980.
58. Belsham B. Glutamate and its role in psychiatric illness. Hum Psychopharmacol 2001, 16:139-146. 10.1002/hup.279, 12404584.
59. Manji HK, Chen G. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol Psychiatry 2002, 7(Suppl 1):S46-56.
60. Gaspar PA, Bustamante ML, Silva H, Aboitiz F. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications. J Neurochem 2009, 111:891-900. 10.1111/j.1471-4159.2009.06325.x, 19686383.
61. Tsai G, Coyle JT. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 2002, 42:165-179. 10.1146/annurev.pharmtox.42.082701.160735, 11807169.
62. Verge B, Alonso Y, Valero J, Miralles C, Vilella E, Martorell L. Mitochondrial DNA (mtDNA) and schizophrenia. Eur Psychiatry 2011, 26:45-56.
63. Clay HB, Sillivan S, Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 2011, 29:311-324. 10.1016/j.ijdevneu.2010.08.007, 20833242.
64. Gentry KM, Nimgaonkar VL. Mitochondrial DNA variants in schizophrenia: association studies. Psychiatr Genet 2000, 10:27-31. 10.1097/00041444-200010010-00005, 10909125.
65. Arnsten AF. Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia. Int J Dev Neurosci 2011, 29:215-223. 10.1016/j.ijdevneu.2011.02.006, 21345366.
66. Anderson G. Neuronal-immune interactions in mediating stress effects in the etiology and course of schizophrenia: role of the amygdala in developmental co-ordination. Med Hypotheses 2011, 76:54-60. 10.1016/j.mehy.2010.08.029, 20843610.
67. Bennett AOM. Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression. Aust N Z J Psychiatry 2008, 42:995-1002. 10.1080/00048670802512073, 19016087.
68. Hahn MW, Kern AD. Comparative genomics of centrality and essentiality in three eukaryotic protein-interaction networks. Mol Biol Evol 2005, 22:803-806. 10.1093/molbev/msi072, 15616139.
69. El Kasmi KC, Smith AM, Williams L, Neale G, Panopoulos AD, Watowich SS, Hacker H, Foxwell BM, Murray PJ. Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. J Immunol 2007, 179:7215-7219.
70. Barrenas F, Chavali S, Holme P, Mobini R, Benson M. Network properties of complex human disease genes identified through genome-wide association studies. PLoS One 2009, 4:e8090. 10.1371/journal.pone.0008090, 2779513, 19956617.
71. Yamayoshi S, Noda T, Ebihara H, Goto H, Morikawa Y, Lukashevich IS, Neumann G, Feldmann H, Kawaoka Y. Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport. Cell Host Microbe 2008, 3:168-177. 10.1016/j.chom.2008.02.001, 2330329, 18329616.
72. Wilson MD, Wang D, Wagner R, Breyssens H, Gertsenstein M, Lobe C, Lu X, Nagy A, Burke RD, Koop BF, Howard PL. ARS2 is a conserved eukaryotic gene essential for early mammalian development. Mol Cell Biol 2008, 28:1503-1514. 10.1128/MCB.01565-07, 2258792, 18086880.
73. Chavali S, Barrenas F, Kanduri K, Benson M. Network properties of human disease genes with pleiotropic effects. BMC Syst Biol 2010, 4:78. 10.1186/1752-0509-4-78, 2892460, 20525321.
74. Sebat J, Levy DL, McCarthy SE. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet 2009, 25:528-535. 10.1016/j.tig.2009.10.004, 19883952.
75. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
76. Ivleva E, Thaker G, Tamminga CA. Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder. Schizophr Bull 2008, 34:734-742. 2632452, 18515820.
77. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373:234-239. 10.1016/S0140-6736(09)60072-6, 19150704.
78. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E, Owen MJ, O'Donovan MC. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 2009, 14:252-260. 10.1038/mp.2008.133, 19065143.
79. Owen MJ, Craddock N, Jablensky A. The genetic deconstruction of psychosis. Schizophr Bull 2007, 33:905-911. 10.1093/schbul/sbm053, 2632314, 17551090.
80. Ghazanfari N, Fernandez KJ, Murata Y, Morsch M, Ngo ST, Reddel SW, Noakes PG, Phillips WD. Muscle specific kinase: organiser of synaptic membrane domains. Int J Biochem Cell Biol 2011, 43:295-298. 10.1016/j.biocel.2010.10.008, 20974278.
81. Maselli RA, Arredondo J, Cagney O, Ng JJ, Anderson JA, Williams C, Gerke BJ, Soliven B, Wollmann RL. Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction. Hum Mol Genet 2010, 19:2370-2379. 10.1093/hmg/ddq110, 2876883, 20371544.
82. Yoritaka A, Shimo Y, Inoue Y, Yoshino H, Hattori N. Nonmotor Symptoms in Patients with PARK2 Mutations. Parkinsons Dis 2011, 2011:473640. 3026966, 21317980.
83. Yamamura Y. The long journey to the discovery of PARK2. Neuropathology 2010,
84. Poulogiannis G, McIntyre RE, Dimitriadi M, Apps JR, Wilson CH, Ichimura K, Luo F, Cantley LC, Wyllie AH, Adams DJ, Arends MJ. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc Natl Acad Sci U S A 2010, 107:15145-15150. 10.1073/pnas.1009941107, 2930574, 20696900.
85. Verkerk AJ, Schot R, Dumee B, Schellekens K, Swagemakers S, Bertoli-Avella AM, Lequin MH, Dudink J, Govaert P, van Zwol AL, et al. Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. Am J Hum Genet 2009, 85:40-52. 10.1016/j.ajhg.2009.06.004, 2706965, 19559397.
86. Kirby BP, Waddington JL, O'Tuathaigh CM. Advancing a functional genomics for schizophrenia: psychopathological and cognitive phenotypes in mutants with gene disruption. Brain Res Bull 2010, 83:162-176. 10.1016/j.brainresbull.2009.09.010, 19800398.
87. Shiozawa S, Kawai K, Okada Y, Tomioka I, Maeda T, Kanda A, Shinohara H, Suemizu H, James Okano H, Sotomaru Y, et al. Gene targeting and subsequent site-specific transgenesis at the beta-actin (ACTB) locus in common marmoset embryonic stem cells. Stem Cells Dev 2011,
88. Dahlen A, Mertens F, Mandahl N, Panagopoulos I. Molecular genetic characterization of the genomic ACTB-GLI fusion in pericytoma with t(7;12). Biochem Biophys Res Commun 2004, 325:1318-1323. 10.1016/j.bbrc.2004.10.172, 15555571.
89. Dahlen A, Fletcher CD, Mertens F, Fletcher JA, Perez-Atayde AR, Hicks MJ, Debiec-Rychter M, Sciot R, Wejde J, Wedin R, et al. Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). Am J Pathol 2004, 164:1645-1653. 10.1016/S0002-9440(10)63723-6, 1615655, 15111311.
90. Silvestre DC, Gil GA, Tomasini N, Bussolino DF, Caputto BL. Growth of peripheral and central nervous system tumors is supported by cytoplasmic c-Fos in humans and mice. PLoS One 2010, 5:e9544. 10.1371/journal.pone.0009544, 2832012, 20209053.
91. Corral J, Anton AI, Quiroga T, Gonzalez-Conejero R, Pereira J, Roldan V, Vicente V, Mezzano D. Influence of the F12 -4 C>T polymorphism on hemostatic tests. Blood Coagul Fibrinolysis 2010, 21:632-639.
92. Kim HJ, Kwon EH, Lee KO, Park IA, Kim SH. Novel deleterious mutation in the F12 gene in a Korean family with severe coagulation factor XII deficiency. Blood Coagul Fibrinolysis 2010, 21:683-686.
93. Gary T, Hafner F, Froehlich H, Stojakovic T, Scharnagl H, Pilger E, Brodmann M. High factor VIII activity, high plasminogen activator inhibitor 1 antigen levels and low factor XII activity contribute to a thrombophilic tendency in elderly venous thromboembolism patients. Acta Haematol 2010, 124:214-217. 10.1159/000321530, 21071930.
94. Messiaen L, Vogt J, Bengesser K, Fu C, Mikhail F, Serra E, Garcia-Linares C, Cooper DN, Lazaro C, Kehrer-Sawatzki H. Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1). Hum Mutat 2011, 32:213-219. 10.1002/humu.21418, 21280148.
95. Harder A, Titze S, Herbst L, Harder T, Guse K, Tinschert S, Kaufmann D, Rosenbaum T, Mautner VF, Windt E, et al. Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5' untranslated region, exon and intron 1. Twin Res Hum Genet 2010, 13:582-594. 10.1375/twin.13.6.582, 21142935.
96. Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS, Cooper DN. The Human Gene Mutation Database: 2008 update. Genome Med 2009, 1:13. 10.1186/gm13, 2651586, 19348700.
97. Erler JT, Linding R. Network-based drugs and biomarkers. J Pathol 2010, 220:290-296.
98. Huang PH, Mukasa A, Bonavia R, Flynn RA, Brewer ZE, Cavenee WK, Furnari FB, White FM. Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc Natl Acad Sci U S A 2007, 104:12867-12872. 10.1073/pnas.0705158104, 1937558, 17646646.
99. Schoeberl B, Pace EA, Fitzgerald JB, Harms BD, Xu L, Nie L, Linggi B, Kalra A, Paragas V, Bukhalid R, et al. Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis. Sci Signal 2009, 2:ra31. 10.1126/scisignal.2000352, 19567914.
100. Aydin D, Filippov MA, Tschape JA, Gretz N, Prinz M, Eils R, Brors B, Muller UC. Comparative transcriptome profiling of amyloid precursor protein family members in the adult cortex. BMC Genomics 2011, 12:160. 10.1186/1471-2164-12-160, 3080314, 21435241.
101. Anliker B, Muller U. The functions of mammalian amyloid precursor protein and related amyloid precursor-like proteins. Neurodegener Dis 2006, 3:239-246. 10.1159/000095262, 17047363.
102. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 2006, 26:9057-9068. 10.1523/JNEUROSCI.1469-06.2006, 16943564.